Healthcare
VC firms invest $37m in Blippar
Company's accounts show the firm is making increasingly large losses, up to ТЃ34.4m in 2017
Synova sells 4Ways to ECI, earns 6x
Synova backed the MBO of 4Ways in 2015 and has helped to scale the firm's operations
EMH invests in Brainlab
Fifth investment from the EMH Digital Growth Fund, a €350m vehicle that closed in 2017
WestBridge Capital backs MBO of AJM Healthcare
GP is investing from its second SME fund, which held a ТЃ50m first close earlier this year
Elbrus invests in Active Component
Deal follows a memorandum of understanding between the company and the Russian government
Nexxus, Capzanine acquire stake in Spanish medical group
Group's founders, Manuel and Jorge Fernandez, will retain the majority stake in the business
Longship-backed Ecura completes two bolt-ons
Deals strengthen Ecura in the Norwegian care market and deepens its footprint in the Oslo region
SHS sells EIT to Johnson & Johnson
Sale ends a two-year holding period for the GP's €125m life sciences investment fund, SHS IV Fonds
IK-backed Colisée bolts on STS Grup
Colisée raised a new term loan of €120m in order to increase its financial capabilities
EMBL sells ViraTherapeutics to trade for €210m
Acquirer signed a collaboration and option agreement with ViraTherapeutics in August 2016
Calculus Capital leads £6m round for Arecor
Albion Capital and Downing Ventures also take part in the funding round
NVM leads £3.2m round for Ridge Pharma
GP contributes ТЃ2.75m towards the funding round for the UK-based pharmaceutical business
Summa Equity acquires HyTest
Investment marks the Nordic private equity firm's first deal in the Finnish market
VC firms in €30m series-D for Miracor
Belgian listed investment fund Quest for Growth takes part in the financing
Vesalius backs Forendo Pharma in €4m round
Additional funding comes after a тЌ12m series-A financing in 2014 and тЌ5.7m of R&D loans
Sixth Element leads £4m series-A for Azeria
Company plans to use the fresh capital to advance its research towards clinical trials
Foresight invests £2.5m in ABL
Foresight Group's equity investment is supported by a debt package from Barclays
Evox Therapeutics raises £35.5m series-B
New backers include Redmile Group, GV, Cowen Healthcare Investments and Panacea Healthcare Venture
Lansdowne et al. in £25m series-B for Genomics
US-based drug developer Vertex Pharmaceuticals led the funding round for the genetic data researcher
Longitude leads £25m Kandy Therapeutics series-C
Recently founded biotech company will advance its menopause drug to the testing phase
PE-backed Vivalto Santé bolts on Capio's French division
French division of hospitals and clinics operator Capio is valued at around €455m
F2i in late-stage acquisition talks for Farmacrimi
Deal is part of the GP's buy-and-build strategy aimed at creating a group of pharmacies across Italy
Argos Wityu acquires AktivOptik
GP draws capital from its seventh vehicle to buy the optician and hearing care chain
Almi Invest backs Beactica
Funds raised are intended to accelerate the drug developer's pipeline of novel cancer therapeutics